DFE Pharma appoints Khatera Alawi as new global director human resources: Goch, Germany Friday, July 24, 2026, 17:00 Hrs [IST ...
CDSCO formalises algorithm change protocol to streamline AI/ML software updates: Peethaambaran Kunnathoor, Chennai In a ...
KPRDO sounds alarm over unauthorised medicine substitution & misleading discount schemes: Nandita Vijayasimha, Bengaluru The ...
CDSCO issues clarification on applications related to compounding of offences: Gireesh Babu, New Delhi Friday, July 24, 2026, ...
Zydus Lifesciences Limited, an innovation-led global lifesciences company, has received permission to conduct a phase III clinical trial of Desidustat for patients with sickle cell disease. Conducted ...
Bluesight and Pfizer Global Hospital & Biosimilars partner to provide source-tagged RFID medications to hospital pharmacies: Alexandria, Virginia Friday, July 24, 2026, 14:00 Hrs ...
Manipal Health IPO opens July 29 at Rs. 560 to Rs. 590 price band, targets Rs. 9,275 crore raise: Our Bureau, Bengaluru Friday, July 24, 2026, 16:30 Hrs [IST] Manipal Health Enter ...
Cipla reported a 39 per cent decline in its net profit of Rs. 789 crore for Q1 FY27, led by lower sales in North America business. The company's revenue stood at Rs. 7,119 crore for the June quarter.
Sun Pharmaceutical Industries Limited announced that the stockholders of Organon & Co. have approved the proposals in connection with the previously announced merger transaction under which Organon is ...
Akums Drugs and Pharma to acquire Oriflame India's manufacturing business: Our Bureau, Mumbai Friday, July 24, 2026, 16:40 Hrs [IST] Akums Drugs and Pharmaceuticals Limited, India ...
US FDA approves GSK’s Jideytro for previously treated ROS1-positive non-small cell lung cancer: London, UK Friday, July 24, 2026, 13:00 Hrs [IST] GSK plc announced the US Food a ...
Monopar Therapeutics begins rolling NDA submission to US FDA for ALXN1840 in Wilson disease: Wilmette, Illinois Friday, July 24, 2026, 15:00 Hrs [IST] Monopar Therapeutics Inc. (M ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results